Replies to post #7178 on Theriva Biologics Inc (TOVX)

[Rymankoly]

Not sure if they have any near term catalyst, the only one I see is for SYN-004:
Plan to announce topline data from Phase 2b proof-of-concept clinical trial (1Q 2017).

They might very well drift lower from here, so I just initiated a position and will add in steps (like I did with ACAD)

Good luck